Parallel Advisors, LLC Tarsus Pharmaceuticals, Inc. Transaction History
Parallel Advisors, LLC
- $4.87 Billion
- Q2 2025
A detailed history of Parallel Advisors, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 48 shares of TARS stock, worth $3,670. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48
Previous 40
20.0%
Holding current value
$3,670
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TARS
# of Institutions
216Shares Held
46.7MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$250 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$238 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$228 Million5.63% of portfolio
-
Jennison Associates LLC2.47MShares$189 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$188 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $2.04B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...